A Phase III Study of 131I Metaiodobenzylguanidine (131I-MIBG) or Crizotinib Added to Intensive Therapy for Children With Newly Diagnosed High-Risk Neuroblastoma (NBL)
Clinical Trial Grant
Administered By
Pediatrics, Hematology-Oncology
Awarded By
Children's Hospital of Philadelphia
Start Date
June 8, 2020
End Date
April 1, 2022
Administered By
Pediatrics, Hematology-Oncology
Awarded By
Children's Hospital of Philadelphia
Start Date
June 8, 2020
End Date
April 1, 2022